Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients

被引：0
|
作者：
Savage, Scott [2 ]
Domagalski, Nathan [2 ]
Hobson, Lindsay [1 ]
Jones, Scott [1 ]
Mack, Brendan [2 ]
Qiu, Yuping [2 ]
Ramirez, Antonio [2 ]
Waltermire, Robert [2 ]
机构：
[1] Bristol Myers Squibb, New Brunswick, NJ USA
[2] Bristol Myers Squibb, Chem & Synthet Dev, New Brunswick, NJ USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
558
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Mechanochemistry Can Reduce Life Cycle Environmental Impacts of Manufacturing Active Pharmaceutical Ingredients
    Galant, Or
    Cerfeda, Giacomo
    McCalmont, Aaron S.
    James, Stuart L.
    Porcheddu, Andrea
    Delogu, Francesco
    Crawford, Deborah E.
    Colacino, Evelina
    Spatari, Sabrina
    ACS SUSTAINABLE CHEMISTRY & ENGINEERING, 2022, 10 (04): : 1430 - 1439
  • [42] India's Road to Independence in Manufacturing Active Pharmaceutical Ingredients: Focus on Essential Medicines
    Cherian, Jerin Jose
    Rahi, Manju
    Singh, Shubhra
    Reddy, Sanapareddy Eswara
    Gupta, Yogendra Kumar
    Katoch, Vishwa Mohan
    Kumar, Vijay
    Selvaraj, Sakthivel
    Das, Payal
    Gangakhedkar, Raman Raghunathrao
    Dinda, Amit Kumar
    Sarkar, Swarup
    Vaghela, Puroshottambhai Devshibhai
    Bhargava, Balram
    ECONOMIES, 2021, 9 (02)
  • [43] A Study on the Optimization of In-Process Inspection Procedure for Active Pharmaceutical Ingredients Manufacturing Process
    Yang, Taho
    Lin, Shin-Yi
    Hung, Yu-Hsiu
    Hong, Chung-Chien
    SUSTAINABILITY, 2022, 14 (06)
  • [44] Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs
    Aitipamula, Srinivasulu
    Chow, Pui Shan
    Tan, Reginald B. H.
    CRYSTENGCOMM, 2009, 11 (09): : 1823 - 1827
  • [45] Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients
    Daniel Capaldi
    Kathy Ackley
    Doug Brooks
    Judy Carmody
    Ken Draper
    Rao Kambhampati
    Matthias Kretschmer
    Daren Levin
    James McArdle
    Bernhard Noll
    Ramesh Raghavachari
    Ipsita Roymoulik
    B. P. (Bob) Sharma
    René Thürmer
    Fran Wincott
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 611 - 626
  • [46] Application of crystallization technologies to process development and manufacture of active pharmaceutical ingredients
    Rose, PR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3344 - U3345
  • [47] Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients
    Capaldi, Daniel
    Ackley, Kathy
    Brooks, Doug
    Carmody, Judy
    Draper, Ken
    Kambhampati, Rao
    Kretschmer, Matthias
    Levin, Daren
    McArdle, James
    Noll, Bernhard
    Raghavachari, Ramesh
    Roymoulik, Ipsita
    Sharma, B. P.
    Thuermer, Rene
    Wincott, Fran
    DRUG INFORMATION JOURNAL, 2012, 46 (05): : 611 - 626
  • [48] Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods
    Simic, Stefan
    Zukic, Erna
    Schmermund, Luca
    Faber, Kurt
    Winkler, Christoph K.
    Kroutil, Wolfgang
    CHEMICAL REVIEWS, 2022, 122 (01) : 1052 - 1126
  • [49] Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development
    Puhlmann, Neele
    Vidaurre, Rodrigo
    Kuemmerer, Klaus
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [50] Challenges and Directions for Regulatory Use of QSARs for Predicting Active Pharmaceutical Ingredients Environmental Toxicity
    Sanderson, Hans
    CURRENT DRUG SAFETY, 2012, 7 (04) : 309 - 312
12345